Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.6945 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.63937 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.66911 | 29 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.58875 | 28 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.57391 | 27 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.72098 | 28 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.67691 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.61169 | 27 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.6108 | 28 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.62946 | 28 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.628 | 28 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.60721 | 28 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.63401 | 28 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.63861 | 28 |